Health
NHS set to pilot GRAIL’s wide-ranging cancer blood test – PMLiVE
Previous study indicates test can detect over 50 cancer types
The UK’s National Health Service (NHS) has signed a deal with healthcare company GRAIL to pilot its novel cancer blood test in 165,000 patients.
The Galleri blood test will be offered to 165,000 patients by NHS England in a new programme aimed at detecting early stage cancers.
The blood test identifies signs of a range of cancer types by searching for small fragments of DNA and RNA from tumours in the bloodstream to determine the presence of cancer.
The NHS will identify programme participants…
-
Noosa News21 hours agoEnsure voices are heard – Proctor
-
Business18 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Noosa News23 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
General22 hours agoReserve Bank board still looking for yesterday’s news